Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Cervical Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 15 articles: HTML format

Single Articles

October 2025
1. BAENA A, Picconi MA, Mendoza L, Ferrera A, et al
   Short-term repeat HPV testing for triaging HPV-positive women in cervical cancer screening.
   Br J Cancer. 2025 Oct 3. doi: 10.1038/s41416-025-03193.
   PubMed     Abstract available
   
   
   September 2025
2. GORI S, Venturelli F, Carozzi F, Giorgi Rossi P, et al
   Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology.
   Br J Cancer. 2025 Sep 11. doi: 10.1038/s41416-025-03161.
   PubMed     Abstract available
   
   
   
3. MATHEWS CS, Sargent A, Cuschieri K, Rebolj M, et al
   HPValidate-human papillomavirus testing with DNA and mRNA assays on self-collected samples in cervical screening: comparison of test characteristics on three self-sampling devices.
   Br J Cancer. 2025;133:665-673.
   PubMed     Abstract available
   
   
   April 2025
4. SU H, Jin X, Kong L, You Y, et al
   The triage role of cytological DNA methylation in women with non-16/18, specifically genotyping high-risk HPV infection.
   Br J Cancer. 2025 Apr 10. doi: 10.1038/s41416-025-03005.
   PubMed     Abstract available
   
   
   October 2024
5. HIRAHARA Y, Shimizu K, Yamasaki S, Iyoda T, et al
   Crucial immunological roles of the invasion front in innate and adaptive immunity in cervical cancer.
   Br J Cancer. 2024 Oct 29. doi: 10.1038/s41416-024-02877.
   PubMed     Abstract available
   
   
   May 2024
6. REBOLJ M, Brentnall AR, Cuschieri K
   Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening.
   Br J Cancer. 2024;130:1733-1743.
   PubMed     Abstract available
   
   
   April 2024
7. PORTNOY A, Pedersen K, Kim JJ, Burger EA, et al
   Vaccination and screening strategies to accelerate cervical cancer elimination in Norway: a model-based analysis.
   Br J Cancer. 2024 Apr 20. doi: 10.1038/s41416-024-02682.
   PubMed     Abstract available
   
   
   January 2024
8. WANG Y, He M, He T, Ouyang X, et al
   Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers.
   Br J Cancer. 2024 Jan 22. doi: 10.1038/s41416-023-02555.
   PubMed     Abstract available
   
   
   November 2023
9. DOWNHAM L, Jaafar I, Rol ML, Nyawira Nyaga V, et al
   Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.
   Br J Cancer. 2023 Nov 16. doi: 10.1038/s41416-023-02490.
   PubMed     Abstract available
   
   
   August 2023
10. CUSCHIERI K, Palmer T, Graham C, Cameron R, et al
    The changing nature of HPV associated with high grade cervical lesions in vaccinated populations, a retrospective study of over 1700 cases in Scotland.
    Br J Cancer. 2023 Aug 10. doi: 10.1038/s41416-023-02386.
    PubMed     Abstract available
    
    
    July 2023
11. KERRISON RS, Jones A, Peng J, Price G, et al
    Inequalities in cancer screening participation between adults with and without severe mental illness: results from a cross-sectional analysis of primary care data on English Screening Programmes.
    Br J Cancer. 2023;129:81-93.
    PubMed     Abstract available
    
    
    April 2023
12. VERHOEF L, Bleeker MCG, Polman N, Steenbergen RDM, et al
    Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.
    Br J Cancer. 2023 Apr 26:1-8. doi: 10.1038/s41416-023-02277.
    PubMed     Abstract available
    
    
    
13. KAMAL M, Lameiras S, Deloger M, Morel A, et al
    Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
    Br J Cancer. 2023 Apr 13. doi: 10.1038/s41416-023-02261.
    PubMed    
    
    
    March 2023
14. MITTELSTADT S, Kelemen O, Admard J, Gschwind A, et al
    Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse.
    Br J Cancer. 2023 Mar 27. doi: 10.1038/s41416-023-02233.
    PubMed     Abstract available
    
    
    
15. GILHAM C, Sargent A, Crosbie EJ, Peto J, et al
    Long-term risks of invasive cervical cancer following HPV infection: follow-up of two screening cohorts in Manchester.
    Br J Cancer. 2023 Mar 23. doi: 10.1038/s41416-023-02227.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.